•   
  •   
  •   

World Russia approves single-dose version of Sputnik V vaccine

22:00  06 may  2021
22:00  06 may  2021 Source:   msn.com

Brazil regulator rejects Sputnik vaccine; Russia cries foul

  Brazil regulator rejects Sputnik vaccine; Russia cries foul RIO DE JANEIRO (AP) — Brazil's health regulator cited safety concerns while rejecting several states' requests to import almost 30 million doses of Russia's Sputnik V vaccine, prompting criticism from the Russian government. The five-person board of the Brazilian Health Regulatory Agency unanimously decided late Monday that consistent and trustworthy data required was lacking for approval of the requests from 10 states, according to a statement. Another four states and two cities have also sought authorization to import the vaccine.

MOSCOW (AP) — Russian authorities gave regulatory approval Thursday to a single-dose version of the country's Sputnik V vaccine, arguing that the move could accelerate the process of achieving herd immunity against the coronavirus.

Named Sputnik Light, the new version is identical to the first dose of the two-dose Sputnik V. The regulatory approval will allow it to be marketed and administered as a separate COVID-19 vaccine.

The jab, however, has yet to complete its own advanced testing needed to ensure its safety and effectiveness in line with established scientific protocols. Russia started human trials of Sputnik Light in January, and the studies are still ongoing, according to official records.

Vaccines aplenty but some Californians struggle to get one

  Vaccines aplenty but some Californians struggle to get one SAN FRANCISCO (AP) — Hearing of excess vaccine and unfilled appointments frustrates Dr. Aaron Roland, a family physician who has been lobbying for doses to inoculate his patients, many of whom are low-income, immigrants or elderly. The San Francisco Bay Area doctor has more than 200 patients who have inquired when he will offer inoculations against the coronavirus. One patient, who is 67, said he walked into a Safeway supermarket because signs said doses were available.

The two-dose Sputnik V will remain “the main source of vaccination in Russia,” said Russian Direct Investment Fund CEO Kirill Dmitriev, whose organization bankrolls the Sputnik shots. Sputnik Light will be exported “to our international partners to help increase the rate of vaccinations in a number of countries in the face of the ongoing fight with the pandemic and new strains of coronavirus,” he said.

Sputnik Light is the fourth domestically developed COVID-19 vaccine approved in Russia. Commenting on the decision to authorize it for use, President Vladimir Putin said Thursday, “It's nice to know that this range of tools (against COVID-19) is expanding.”

Russian Health Minister Mikhail Murashko said authorizing a fourth jab will help speed up the process of forming herd immunity against the virus. Most scientists believe at least 70% of a population needs to be immunized to achieve herd immunity against COVID-19, but the exact threshold is still unknown.

Russia, facing lags, turns to China to produce Sputnik shots

  Russia, facing lags, turns to China to produce Sputnik shots TAIPEI, Taiwan (AP) — Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot. Russia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It's a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia's vaccine, as theRussia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It's a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia's vaccine, as the U.S.

The Russian Direct Investment Fund's Dmitriev, said in a statement Thursday that “the single dose regimen solves the challenge of immunizing large groups in a shorter time, which is especially important during the acute phase of the spread of coronavirus, achieving herd immunity faster.”

Russia faced criticism last year for authorizing Sputnik V before advanced trials had even started and for offering it to medical workers while those trials were underway. The criticism was blunted by a study published in February in the British medical journal The Lancet, which said the vaccine appeared safe and 91% effective against COVID-19 based on a trial involving about 20,000 people in Russia.

Two other Russian vaccines — EpiVacCorona and CoviVac — also received regulatory approval before completing large-scale testing. No data on the efficacy of the vaccines has been released.

Despite having several vaccines available and being one of the first countries to start immunizing its population, Russia is currently lagging behind a number of nations in terms of its vaccination rates.

According to Deputy Prime Minister Tatyana Golikova, 13.4 million people in Russia, or just 9% of Russia's population of 146 million, had received at least one dose of a COVID-19 vaccine as of Thursday, while 9.4 million — 6% of the population— have been fully vaccinated.

Experts have questioned whether Russia will be able to meet the government's targets of vaccinating 30 million people by mid-June and nearly 69 million by August.

States scale back vaccine orders as interest in shots wanes .
States asked the federal government this week to withhold staggering amounts of COVID-19 vaccine amid plummeting demand for the shots, contributing to a growing U.S. stockpile of doses. From South Carolina to Washington, states are requesting the Biden administration send them only a fraction of what's been allocated to them.From South Carolina to Washington, states are requesting the Biden administration send them only a fraction of what's been allocated to them. The turned-down vaccines amount to hundreds of thousands of doses this week alone, providing a stark illustration of the problem of vaccine hesitancy in the U.S.

usr: 0
This is interesting!